These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8829882)

  • 21. CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
    Zhu X; Qiao Y; Liu W; Wang W; Shen H; Lu Y; Hao G; Zheng J; Tian Y
    Tumour Biol; 2016 Apr; 37(4):4569-77. PubMed ID: 26503215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature.
    Pricola Fehnel K; Duggins-Warf M; Zurakowski D; McKee-Proctor M; Majumder R; Raber M; Han X; Smith ER
    J Neurosurg Pediatr; 2016 Oct; 18(4):396-407. PubMed ID: 27314542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urine cell-free microRNA as biomarkers for transitional cell carcinoma.
    Geva GA; Gielchinsky I; Aviv N; Max KEA; Gofrit ON; Gur-Wahnon D; Ben-Dov IZ
    BMC Res Notes; 2017 Nov; 10(1):641. PubMed ID: 29187235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic fibroblast growth factor in the urine of children with voiding pathology.
    Bägli DJ; Van Savage JG; Khoury AE; Carr M; McLorie GA
    J Urol; 1997 Sep; 158(3 Pt 2):1123-7. PubMed ID: 9258154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report.
    Lodde M; Mian C; Wiener H; Haitel A; Pycha A; Marberger M
    Urology; 2001 Sep; 58(3):362-6. PubMed ID: 11549481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma.
    Lotan Y; OʼSullivan P; Raman JD; Shariat SF; Kavalieris L; Frampton C; Guilford P; Luxmanan C; Suttie J; Crist H; Scherr D; Asroff S; Goldfischer E; Thill J; Darling D
    Urol Oncol; 2017 Aug; 35(8):531.e15-531.e22. PubMed ID: 28366272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical study of urine basic fetoprotein and urine polyamine as tumor markers in epithelial cancer of the urinary tract.
    Sato D; Kase T; Tajima M; Sawamura Y; Matsushima M
    Int J Urol; 2001 May; 8(5):217-21. PubMed ID: 11328421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma.
    Matsuzaki K; Fujita K; Jingushi K; Kawashima A; Ujike T; Nagahara A; Ueda Y; Tanigawa G; Yoshioka I; Ueda K; Hanayama R; Uemura M; Miyagawa Y; Tsujikawa K; Nonomura N
    Oncotarget; 2017 Apr; 8(15):24668-24678. PubMed ID: 28160564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Novel NMP22 quick qualitative analysis (BladderChek NMP22) for the diagnosis of urothelial tumor].
    Minagawa T; Nishizawa S; Kamigaito T; Okaneya T
    Nihon Hinyokika Gakkai Zasshi; 2006 Jan; 97(1):20-6. PubMed ID: 16485550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
    Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
    Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progression.
    Thalmann GN; Dewald B; Baggiolini M; Studer UE
    J Urol; 1997 Oct; 158(4):1340-4. PubMed ID: 9302115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B domain containing Tenascin-C: a new urine marker for surveillance of patients with urothelial carcinoma of the urinary bladder?
    Gecks T; Junker K; Franz M; Richter P; Walther M; Voigt A; Neri D; Kosmehl H; Wunderlich H; Kiehntopf M; Berndt A
    Clin Chim Acta; 2011 Oct; 412(21-22):1931-6. PubMed ID: 21763295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladder.
    Watson JA; Burling K; Fitzpatrick P; Kay E; Kelly J; Fitzpatrick JM; Dervan PA; McCann A
    BJU Int; 2009 Mar; 103(5):694-7. PubMed ID: 19040529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary basic fibroblast growth factor in bladder cancer patients. Histopathological correlation and clinical potential.
    Gravas S; Bosinakou I; Kehayas P; Giannopoulos A
    Urol Int; 2004; 73(2):173-7. PubMed ID: 15331904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.
    Heilmann RM; McNiel EA; Grützner N; Lanerie DJ; Suchodolski JS; Steiner JM
    BMC Vet Res; 2017 Apr; 13(1):112. PubMed ID: 28431528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
    Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
    Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Value of Liquid-Based Cytology in Urothelial Carcinoma Diagnosis: A Systematic Review and Meta-Analysis.
    Luo Y; She DL; Xiong H; Yang L; Fu SJ
    PLoS One; 2015; 10(8):e0134940. PubMed ID: 26241896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detection.
    Salomo K; Huebner D; Boehme MU; Herr A; Brabetz W; Heberling U; Hakenberg OW; Jahn D; Grimm MO; Steinbach D; Horstmann M; Froehner M; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1757-1769. PubMed ID: 28484844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients.
    Lin RY; Argenta PA; Sullivan KM; Adzick NS
    Clin Cancer Res; 1995 Mar; 1(3):327-31. PubMed ID: 9815988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.